Oral Pilocarpine for Post-Irradiation Xerostomia in Patients with Head and Neck Cancer
Jonas T. Johnson, Susan C. Gallagher, Charles C. Muscoplat(Utah State University), David Ng(IR Dynamics (United States)), W. James Nethery(Loma Linda University), Philip C. Fox(National Institute of Dental and Craniofacial Research), Gerald A. Ferretti(University of Kentucky), Ingrid H. Valdez(National Institute of Dental and Craniofacial Research)
Cited by 483
Related Papers
The Extracapsular Spread of Tumors in Cervical Node Metastasis
|Archives of Otolaryngology - Head and Neck Surgery|1981|371
A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients.
|Journal of Clinical Oncology|1993|292
Oral pilocarpine for radiation-induced xerostomia: Integrated efficacy and safety results from two prospective randomized clinical trials
|International Journal of Radiation Oncology*Biology*Physics|1995|139